EXPERIENCE WITH THE USE OF EVOLOCUMAB THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (IN KARELIA REPUBLIC)
Aim: to evaluate the efficacy and safety of the use of evolocumab in patients with familial hypercholesterolemia (FH).Materials and methods: Fifteen patients with a definite FH were treated with PCSK9 inhibitors, in 11 patients with a history of CAD. Eight patients (53.3%) received evolocumab (Repat...
Main Authors: | V. A. Korneva, T. Yu. Kuznetsova, N. N. Natal’ya N. Vezikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
InterMedservice
2020-06-01
|
Series: | Евразийский Кардиологический Журнал |
Subjects: | |
Online Access: | https://www.heartj.asia/jour/article/view/6206 |
Similar Items
-
Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01) -
Familial homozygous hypercholesterolemia in children: early diagnosis and treatment
by: I. V. Leontyeva
Published: (2021-09-01) -
Modern strategy of diagnosis and treatment of children with heterozygous familial hypercholesterolemia
by: I. V. Leontyeva
Published: (2020-09-01) -
Coronary heart disease development in heterozygotic form of familial hypercholesterolemia
by: P. P. Malyshev, et al.
Published: (2006-10-01) -
SUBFRACTIONS OF ATHEROGENIC APOB-LIPOPROTEIDES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
by: E. A. Utkina, et al.
Published: (2017-08-01)